KOD Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 14.95%, SMA50 8.03%, SMA200 89.29%). The stock’s 14-day RSI is 59.83 (neutral), while the ATR of 2.1 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -10.26% below its high and over 1357.29% above its low. Average 10-day trading volume of 624.28 thousand shares is below the 3-month average of 902.08 thousand, indicating normal recent market interest.

Kodiak Sciences Inc. has 52.82 million shares outstanding. The public float is 32.42 million shares, elevated short interest at 7.74% of float. This equals 2.52 million shares. The short ratio is 4.26 days. Institutional investors hold 95.57% of the float. Insiders own 5.24%. BAKER FELIX holds 15.62 million shares, PERLROTH VICTOR has 2.17 million shares and BAKER BROS. ADVISORS LP has 1.56 million shares. Over the past six months, insider transactions show net selling. They sold 4.70 thousand shares across 2 transactions.

Kodiak Sciences Inc. generated EPS of -$4.12 over the past year. Five-year average earnings growth is -21.78%. Wall Street analysts project EPS growth of -1.26% annually over the next five years. The latest quarter delivered EPS of -$0.94. The next quarter is forecast at -$1.03. Next year's EPS is expected at $39.53. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 9 Buy ratings, 5 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $80.00 to $5.00. The high target offers 142.87% upside. The low target suggests -84.82% downside. The mean target is $30.94. This offers -6.07% upside. Kodiak Sciences Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 07, 2026, missed forecasts by 1.08%. The prior quarter beat by 1.96%. Over the last six quarters, Apple has recorded several small beats. These include -6.67% in March 27, 2025.

Kodiak Sciences Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.95. This means the shares are trading above this model’s fair value.

Kodiak Sciences Inc. (NASDAQ:KOD) closed at $32.94 USD, losing -$1.12 (-3.29%) from the previous close of $34.06. The stock is currently mid-range between its 52-week high and low $3.43 and $47.84. With a market capitalization of about $1.74 billion, Kodiak Sciences Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.21). Key stats such as the average daily volume over the past year has been around 1.10 million shares, volume is running light vs its 52-week average. Headquartered in Palo Alto, CA, Kodiak Sciences Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Victor Perlroth, the company employs approximately 109 people and listed since October 04, 2018. Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina.

Kodiak Sciences Inc. trades at a P/E ratio of -8.93, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 18.38 reflecting a rich premium to book value. The P/FCF stands at -11.9, also below market averages. Compared to sector medians, Kodiak Sciences Inc. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Our AI price prediction model suggests that Kodiak Sciences Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.11%, with price expected at $29.61 by June 29, 2026, within a range of $27.75 to $31.53 3-Month Outlook: Projected rise of 167.4%, reaching $88.08 by September 11, 2026, with a range of $87.57 to $88.64. 1-Year Outlook: Projected gain of 30.57%, with price at $43.01 by June 15, 2027, within a range of $40.46 to $45.83.

Kodiak Sciences Inc. (NASDAQ:KOD) shares are flat -4.72% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Kodiak Sciences Inc. trading at a premium to the broader market with a P/E of -8.93. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $52.35, suggesting 58.93% upside. Our AI forecast model points to short-term weakness (-10.11% over two weeks), a medium-term rise (167.4% over three months), and a longer-term gain (30.57% over one year), with expected trading ranges indicating moderate volatility.